MELE, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 47
NA - Nord America 36
AS - Asia 4
Totale 87
Nazione #
IT - Italia 40
US - Stati Uniti d'America 36
CN - Cina 3
AT - Austria 2
CZ - Repubblica Ceca 2
DE - Germania 2
GB - Regno Unito 1
KR - Corea 1
Totale 87
Città #
Florence 30
Ashburn 8
Sesto Fiorentino 5
Noto 4
Washington 4
Shanghai 3
New York 2
Vienna 2
Cirò Marina 1
Los Angeles 1
Seoul 1
Totale 61
Nome #
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients 23
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 21
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 20
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 16
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 12
Totale 92
Categoria #
all - tutte 843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 843


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202311 0 0 0 0 0 0 7 0 0 0 4 0
2023/202481 2 2 22 20 8 15 8 1 1 2 0 0
Totale 92